The effect of CYP2C19 polymorphism on Japanese patients simultaneously receiving calcineurin inhibitor and voriconazole post hematopoietic stem cell transplant
Not Applicable
Recruiting
- Conditions
- hematopoietic diseases
- Registration Number
- JPRN-UMIN000010863
- Lead Sponsor
- Keio University School of Medicine, Divison of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with allergic reaction to calcineurin inhibitors or voriconazole 2) Any other patient, whom the treating physician has declared inappropriate for study enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of CYP2C19 polymorphism on the blood concentration level of calcineurin inhibitors and voriconazole
- Secondary Outcome Measures
Name Time Method